SHAREHOLDERS' EQUITY (DEFICIT) (Narrative) (Details) $ / shares in Units, $ / shares in Units, ₪ in Thousands, $ in Thousands |
|
|
|
|
1 Months Ended |
5 Months Ended |
7 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
Nov. 12, 2026
$ / shares
|
Jun. 12, 2025
CAD ($)
shares
|
Nov. 12, 2024
CAD ($)
shares
|
Nov. 12, 2024
USD ($)
$ / shares
|
May 08, 2023
CAD ($)
shares
|
May 08, 2023
USD ($)
$ / shares
|
Jul. 31, 2025
CAD ($)
shares
|
Jul. 31, 2025
USD ($)
$ / shares
shares
|
Jul. 30, 2025
CAD ($)
$ / shares
shares
|
Jul. 30, 2025
USD ($)
$ / shares
|
May 26, 2025
CAD ($)
Shares
$ / shares
|
May 26, 2025
CAD ($)
Shares
$ / shares
|
Oct. 31, 2024
CAD ($)
Shares
$ / shares
shares
|
Feb. 29, 2024
ILS (₪)
|
Feb. 28, 2023
CAD ($)
shares
|
Feb. 28, 2023
USD ($)
$ / shares
shares
|
May 26, 2025
CAD ($)
|
Dec. 31, 2025
CAD ($)
shares
|
Dec. 31, 2025
CAD ($)
shares
|
Dec. 31, 2025
CAD ($)
$ / shares
shares
|
Dec. 31, 2024
CAD ($)
Shares
$ / shares
shares
|
Dec. 31, 2023
CAD ($)
Shares
$ / shares
shares
|
Dec. 31, 2025
ILS (₪)
shares
|
Nov. 12, 2024
$ / shares
|
Oct. 31, 2024
$ / shares
|
Feb. 29, 2024
CAD ($)
|
Feb. 29, 2024
ILS (₪)
|
May 08, 2023
USD ($)
$ / shares
shares
|
Feb. 28, 2023
USD ($)
$ / shares
shares
|
Oct. 31, 2022
CAD ($)
|
Oct. 31, 2022
USD ($)
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,894,812
|
5,894,812
|
5,894,812
|
3,085,452
|
|
5,894,812
|
|
|
|
|
|
|
|
|
| Proceeds from issuing shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,065,000
|
|
$ 944,000
|
$ 1,688,000
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants issued per common share | $ / shares |
|
$ 3.43
|
|
|
$ 4.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from warrants recorded as Share capital and premium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,154,000
|
$ 7,253,000
|
|
|
|
|
|
|
|
|
|
| Weighted average value of each option grant | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3
|
$ 6.6
|
|
|
|
|
|
|
|
|
|
| Number of share options granted | Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,305
|
500
|
|
|
|
|
|
|
|
|
|
| Share-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,000
|
|
$ 369,000
|
$ 225,000
|
|
|
|
|
|
|
|
|
|
| Repayments of borrowings, classified as financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,810,000
|
|
3,834,000
|
$ 4,827,000
|
|
|
|
|
|
|
|
|
|
| Borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15,269,000
|
15,269,000
|
$ 15,269,000
|
$ 15,611,000
|
|
|
|
|
|
|
|
|
|
|
| Common shares issued upon RSUs vested | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
9,167
|
|
|
|
|
|
|
|
|
|
| Common shares issued upon partial conversion of convertible debentures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,395,000
|
1,395,000
|
|
$ 0
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares issued upon conversion | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
625,461
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Professional fees |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
912,000
|
|
724,000
|
$ 852,000
|
|
|
|
|
|
|
|
|
|
| L5 Capital [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
82,082
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
82,082
|
|
|
|
| Par value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7
|
|
|
|
| Exercise price of warrants issued per common share | $ / shares |
|
|
|
|
|
|
$ 9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Term of warrants |
|
|
|
|
|
36 months
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Repayments of borrowings, classified as financing activities |
|
|
|
|
|
$ 839,000
|
$ 616
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
|
|
2,050,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value per share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 2.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuing shares |
|
|
|
|
|
|
|
|
|
$ 5,622,000
|
$ 4,100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants issued per common share | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 3.43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amount of total direct and incremental costs incurred |
|
|
|
|
|
|
|
$ 868,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amount of direct and incremental costs incurred in cash |
|
|
|
|
|
|
|
557,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amount of direct and incremental costs incurred in share based payment |
|
|
|
|
|
|
|
311,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Focus [Member] | IMC Holdings Ltd [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of issued and outstanding shares held |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
74.00%
|
74.00%
|
|
|
|
|
| Discounted Cash Flow Approach | ₪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
₪ 3,100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total purchase price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 314,000
|
₪ 819
|
|
|
|
|
| Description of method of measuring fair value of instruments or interests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As a result, the Company issued an aggregate of 128,818 common shares at a deemed price of $2.44 per Common Share, equal to the 10-day volume weighted average price of the common shares on the CSE ending on May 26, 2025, the date in which the Company received disinterested shareholders’ approval to complete the Focus Transaction (the “Closing Date”).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Difference between estimated Focus Purchase Price and actual amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,558,000
|
|
|
|
|
|
| Share Capital [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common shares issued upon partial conversion of convertible debentures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,651,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Life Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
471,375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
471,375
|
|
|
| Par value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.5
|
|
|
| Proceeds from issuing shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,705,000
|
$ 3,535
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants issued per common share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Term of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36 months
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Direct and incremental transaction costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 334,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Concurrent Offering [Member] | Non-brokered private placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
386,195
|
|
|
|
|
|
|
|
|
|
|
|
|
|
386,195
|
|
|
| Par value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.5
|
|
|
| Proceeds from issuing shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,854,000
|
$ 2,896
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants issued per common share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Term of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36 months
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total concurrent offering units | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
193,333
|
193,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| January - February 2023 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,027,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,277
|
|
|
| Transaction costs incurred for common share issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
268,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| January - February 2023 Warrants [Member] | Share Capital [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from warrants recorded as Share capital and premium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,754,000
|
$ 1,319
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Transaction costs incurred for common share issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 66,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| May 2023 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative liability |
|
|
|
|
|
226,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 166
|
|
|
|
| May 2023 Warrants [Member] | Share Capital [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from warrants recorded as Share capital and premium |
|
|
|
|
|
$ 613,000
|
$ 450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| November 2024 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Transaction costs incurred for common share issuance |
|
|
|
$ 1,154,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Direct and incremental transaction costs |
|
|
|
48,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Recorded as deduction from share capital and premium |
|
|
|
$ 40,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| November 2024 Warrants [Member] | Non-brokered private placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
742,517
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.88
|
|
|
|
|
|
|
|
| Proceeds from issuing shares |
|
|
|
|
$ 2,138
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants issued per common share | $ / shares |
|
|
|
|
$ 4.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Direct and incremental transaction costs |
|
|
|
$ 88,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| November 2024 Warrants [Member] | Share Capital [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Transaction costs incurred for common share issuance |
|
|
|
$ 984,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Share [Member] | Private Placements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuing shares |
|
|
|
|
|
|
|
2,070,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
496,000
|
|
|
|
|
|
|
|
|
|
|
| (Gain) loss on revaluation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56,000
|
|
|
|
|
|
|
|
|
|
|
| Pre Funded Warrants [Member] | Private Placements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
648,000
|
648,000
|
648,000
|
|
|
648,000
|
|
|
|
|
|
|
|
|
| Proceeds from issuing shares |
|
|
|
|
|
|
|
1,460,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants issued per common share | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
|
|
|
|
|
|
|
| Amount received on account of financial instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 944,000
|
$ 944,000
|
$ 944,000
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Shares [Member] | Private Placements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuing shares |
|
|
|
|
|
|
|
$ 2,092,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of expected stock price volatility of warrant shares |
|
|
|
|
|
|
|
66.00%
|
66.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of risk-free interest rate of warrant shares |
|
|
|
|
|
|
|
3.15%
|
3.15%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Finder Warran [Member] | Private Placements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of expected stock price volatility of warrant shares |
|
|
|
|
|
|
|
66.10%
|
66.10%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of risk-free interest rate of warrant shares |
|
|
|
|
|
|
|
3.96%
|
3.96%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amount of direct and incremental costs incurred in share based payment |
|
|
|
|
|
|
|
$ 311,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17.00%
|
17.00%
|
17.00%
|
|
|
17.00%
|
|
|
|
|
|
|
|
|
| Various Institutions [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,832,000
|
$ 8,000
|
| Ewave Group Ltd [Member] | Focus [Member] | IMC Holdings Ltd [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of issued and outstanding shares held |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26.00%
|
26.00%
|
|
|
|
|
| Unrelated Service Provider [Member] | Debt Settlement Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
52,380
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Professional fees |
|
|
$ 190,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pure Equity Ltd [Member] | Consulting Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
140,000
|
140,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants issued per common share | $ / shares |
|
|
|
|
|
|
|
|
$ 2.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amount of one time cash payment |
|
|
|
|
|
|
|
|
$ 260
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-Independent Director [Member] | Life Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants issued per common share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Term of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36 months
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shared subscribed | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,950
|
21,950
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Value of shared subscribed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 222,000
|
$ 165
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Guarantor (Chairman & CEO) [Member] | Pre Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.88
|
|
|
|
|
|
|
| Common shares issued as debts settlement with related parties | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
110,576
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants issued for common shares | Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
152,701,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants issued per common share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 440,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amount of common shares recognized as part of permanent equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 318,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Guarantor (Chairman & CEO) [Member] | Various Institutions [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Personal Guarantee Value (Benefit) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 758,000
|
$ 560
|
| Chairman Of Board, Chief Executive Officer And Main Shareholder [Member] | IMC Holdings Ltd [Member] | Loan Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 751,000
|
$ 751,000
|
$ 751,000
|
|
|
₪ 1,750
|
|
|
|
|
|
|
|
|
| Loan maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
| Discount on balance of liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,000
|
$ 33,000
|
33,000
|
|
|
₪ 85
|
|
|
|
|
|
|
|
|
| Chairman Of Board, Chief Executive Officer And Main Shareholder [Member] | Pre Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants issued for common shares | Shares |
|
|
|
|
|
|
|
|
|
|
|
152,701
|
152,701
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrant | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chairman Of Board, Chief Executive Officer And Main Shareholder [Member] | Pre Funded Warrants [Member] | Derivative Liability [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrant | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 2.44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative, fair value |
|
|
|
|
|
|
|
|
|
|
|
$ 372,000
|
$ 372,000
|
|
|
|
|
$ 372,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Revaluation income of change in fair value of derivative liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 124,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 Share Incentive Plan" (the "2018 Plan") [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average fair value of each option grant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.24
|
$ 1.24
|
$ 1.24
|
$ 4.7
|
|
|
|
|
|
|
|
|
|
|
| Weighted average remaining contractual life for the share options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 months 2 days
|
|
1 year 9 months 10 days
|
3 years 9 months 3 days
|
|
|
|
|
|
|
|
|
|
| Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of ordinary shares reserved for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares reserved for issuance | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,768
|
28,768
|
28,768
|
|
|
28,768
|
|
|
|
|
|
|
|
|
|
|